BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vitorino C, Silva S, Bicker J, Falcão A, Fortuna A. Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges. Drug Discov Today 2019;24:1911-23. [PMID: 31181188 DOI: 10.1016/j.drudis.2019.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zorkina Y, Abramova O, Ushakova V, Morozova A, Zubkov E, Valikhov M, Melnikov P, Majouga A, Chekhonin V. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 2020;25:E5294. [PMID: 33202839 DOI: 10.3390/molecules25225294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Zhu Y, Liu C, Pang Z. Dendrimer-Based Drug Delivery Systems for Brain Targeting. Biomolecules 2019;9:E790. [PMID: 31783573 DOI: 10.3390/biom9120790] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 12.3] [Reference Citation Analysis]
3 A P, Agrawal M, Dethe MR, Ahmed H, Yadav A, Gupta U, Alexander A. Nose-to-brain drug delivery for the treatment of Alzheimer's Disease: Current advancements and challenges. Expert Opin Drug Deliv 2022. [PMID: 35040728 DOI: 10.1080/17425247.2022.2029845] [Reference Citation Analysis]
4 Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Gupta U, Kesharwani P, Ravichandiran V, Kumar P, Naidu VGM, Murty US, Ajazuddin, Alexander A. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J Control Release 2020;327:235-65. [PMID: 32739524 DOI: 10.1016/j.jconrel.2020.07.044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
5 Xu J, Tao J, Wang J. Design and Application in Delivery System of Intranasal Antidepressants. Front Bioeng Biotechnol 2020;8:626882. [PMID: 33409272 DOI: 10.3389/fbioe.2020.626882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gonçalves J, Alves G, Carona A, Bicker J, Vitorino C, Falcão A, Fortuna A. Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration. Pharm Res 2020;37:74. [PMID: 32215749 DOI: 10.1007/s11095-020-02786-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Lee D, Minko T. Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics 2021;13:2049. [PMID: 34959331 DOI: 10.3390/pharmaceutics13122049] [Reference Citation Analysis]
8 Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-kubati SS. Recent progress in nanocarriers for direct nose to brain drug delivery. Journal of Drug Delivery Science and Technology 2021;64:102642. [DOI: 10.1016/j.jddst.2021.102642] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]